FDA Insight
U.S. Food and Drug Administration
Overview
Episodes
Details
Join Dr. Anand Shah, FDA's Deputy Commissioner for Medical and Scientific Affairs, and other FDA leaders as they provide their insight into issues facing the agency, including the COVID-19 pandemic and other emerging topics.
Recent Episodes
JAN 19, 2021
Pandemic Recovery and Preparedness Plan (PREPP)
Join FDA Commissioner Stephen M. Hahn, M.D. and Deputy Commissioner for Medical and Scientific Affairs Anand Shah, M.D. for their final episode of FDA Insight as they discuss FDA’s Pandemic Recovery and Preparedness Plan, or PREPP. After this episode, the program is scheduled to go on hiatus.
11 MIN
JAN 12, 2021
New Era of Smarter Food Safety
Frank Yiannas, FDA’s Deputy Commissioner for Food Policy and Response, joins Dr. Shah for a discussion on the New Era of Smarter Food Safety and how its blueprint impacts FDA’s COVID-19 response.
19 MIN
JAN 5, 2021
Compounded Drugs
Gail Bormel from the Office of Compliance in FDA’s Center for Drug Evaluation and Research joins Dr. Shah for a discussion on drug compounding and its contribution to fighting COVID-19.
10 MIN
DEC 15, 2020
Advanced Manufacturing
Dr. Jeffrey C. Baker, Deputy Director of the FDA’s Office of Biotechnology Products in the Center for Drug Evaluation and Research, joins Dr. Shah for a discussion on how FDA’s efforts help innovation and implementation of Advanced Manufacturing technologies regarding food and drug safety.
11 MIN
DEC 8, 2020
Minority Health and Health Equity
Dr. Anand Shah and Rear Adm. Richardae Araojo, Associate Commissioner of Minority Health, discuss the FDA’s efforts to address minority health disparities among diverse racial and ethnic populations.
13 MIN
See all episodes